research

Austin Texas Has The Potential To Become A Hotbed For Psychedelic Research

Feb 3, 2022

Algernon Pharmaceuticals’ Latest DMT Study Establishes Ideal Treatment Period

Nov 2, 2021

MINDCURE Names Tarik Lebbadi as Chief Operating Officer

Mar 15, 2021

Numinus to expand state-of-the-art psychedelics research laboratory

Mar 9, 2021

Pandemic Provides Opportunity for Evaluation of Mental Health; MindCure and MindMed Lead With Ibogaine

Mar 8, 2021

Regulatory Approvals Place Numinus Lab at the Forefront of Global Psychedelics Research

Mar 4, 2021

Numinus and Syreon Provide Psilocybin Compassionate Access Trial Update

Mar 2, 2021

Numinus’ Dr Evan Wood: There is Nothing Like Psychedelics to Treat Mental Health Challenges

Feb 22, 2021

Microdosing DMT for Stroke: Algernon Pharmaceuticals Launches New Clinical Research Program

Feb 12, 2021